InsidersTradesSigma
Discover the full insider trade history of Estrella Immunopharma, Inc., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €50.8m. The latest transaction was reported on 5 October 2023 (J). Among the most active insiders: Owl Creek Asset Management, L.P.. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
1 of 1 declaration